TEVA 5507 Pill — RED CAPSULE, 18mm — Fluoxetine
| Imprint | TEVA / 5507 |
|---|---|
| Colour | RED |
| Shape | CAPSULE |
| Size | 18 |
| Strength | OLANZAPINE 12 mg;FLUOXETINE HYDROCHLORIDE 50 mg |
| Dosage form | Capsule |
| Manufacturer | AvKARE, Inc. |
| NDC | 42291-656 |
| Schedule | — |
| Availability | Prescription only |
| Ingredients | OLANZAPINE[OLANZAPINE];FLUOXETINE HYDROCHLORIDE[FLUOXETINE] |
What does this imprint mean?
The imprint "TEVA 5507" is a code stamped or printed on the tablet or capsule by the manufacturer, used to identify the drug, its strength and the maker.
Active ingredient
Fluoxetine
Uses and warnings
BOXED WARNING: BOXED WARNING - Suicidal Thoughts and Behaviors: "Antidepressants increased the risk of suicidal thoughts and behavior in children, adolescents, and young adults in short-term studies." Monitoring is required for all ages starting antidepressant therapy. "Fluoxetine is not approved for use in children less than 7 years of age." Key Warnings Include: - Serotonin syndrome risk when combined with other serotonergic drugs - Allergic reactions and rash (discontinue if occurs) - Activation of mania/hypomania in bipolar patients - Seizure risk in predisposed individuals - Weight loss and appetite changes - Abnormal bleeding (especially with NSAIDs/warfarin) - Angle-closure glaucoma in susceptible patients - Hyponatremia/SIADH - QT interval prolongation - Cognitive and motor impairment potential --- | BOXED WARNING - Suicidal Thoughts and Behaviors: "Antidepressants increased the risk of suicidal thoughts and behavior in children, adolescents, and young adults in short-term studies." Monitoring is required for all ages starting antidepressant therapy. "Fluoxetine is not approved for use in children less than 7 years of age." Key Warnings Include: - Serotonin syndrome risk when combined with other serotonergic drugs - Allergic reactions and rash (discontinue if occurs) - Activation of mania/hypomania in bipolar patients - Seizure risk in predisposed individuals - Weight loss and appetite changes - Abnormal bleeding (especially with NSAIDs/warfarin) - Angle-closure glauc
Fluoxetine is indicated for: - "Acute and maintenance treatment of Major Depressive Disorder" - "Acute and maintenance treatment of obsessions and compulsions in patients with Obsessive Compulsive Disorder (OCD)" - "Acute and maintenance treatment of binge-eating and vomiting behaviors in patients with moderate to severe Bulimia Nervosa" - "Acute treatment of Panic Disorder, with or without agoraphobia" ---
How to identify this pill
- • Check the imprint matches exactly: "TEVA 5507".
- • Confirm the colour (RED) and shape (CAPSULE).
- • Compare the size (18) against a ruler if possible.
- • When in doubt, confirm with a pharmacist before taking any medication.
Similar-looking pills
BP 301
RED CAPSULE · Folic Acid
IG273 5
RED CAPSULE · Ramipril
L454
RED CAPSULE · Acetaminophen
44 519
RED CAPSULE · Acetaminophen
L922
RED CAPSULE · Acetaminophen
TEVA 3171
RED CAPSULE · Clindamycin
H 148
RED CAPSULE · Lisinopril
5MG
RED CAPSULE · Zolpidem
GG 580
RED CAPSULE · Hydrochlorothiazide
L 5
RED CAPSULE · Acetaminophen
CE273 5mg
RED CAPSULE · Ramipril
SMV 80
RED CAPSULE · Simvastatin
Other pills of Fluoxetine
40 A107
BLUE CAPSULE · Fluoxetine
PLIVA 648
WHITE;GREEN CAPSULE · Fluoxetine
7188 9
BLUE OVAL · Fluoxetine
SG 114
GREEN CAPSULE · Fluoxetine
SG 114
GREEN CAPSULE · Fluoxetine
PLIVA 647
WHITE CAPSULE · Fluoxetine
FL 20
WHITE OVAL · Fluoxetine
SG 114
GREEN CAPSULE · Fluoxetine
E 88
GREEN CAPSULE · Fluoxetine
R 0150
BLUE OVAL · Fluoxetine
FL 20
WHITE OVAL · Fluoxetine
566 20
WHITE OVAL · Fluoxetine
Official references
Source: FDA Structured Product Label via NLM Pillbox archive (retired 2021); source file 7cad8747-2c88-a06d-e053-2a91aa0a7722.xml